Viking Global Investors Lp Bridge Bio Pharma, Inc. (BBIO) insider trading activity

VIKING GLOBAL INVESTORS LP Transaction History

Date	Transaction	Value	Shares Traded
Jul 18 2023	SELL Open market or private sale	$52,500,000 $35.0 p/Share	1,500,000
Jun 27 2019	BUY Open market or private purchase	$80,000,300 $17.0 p/Share	4,705,900
Jun 27 2019	BUY Conversion of derivative security	-	21,915,091

Also insider at

Wayfair Inc. Consumer Cyclical

> 10% Shareholder

EDIT

Editas Medicine, Inc. Healthcare

> 10% Shareholder

FDC

FIRST DATA CORP

> 10% Shareholder

ABUS

Arbutus Biopharma Corp Healthcare

> 10% Shareholder

MYOV

Myovant Sciences Ltd. Healthcare

> 10% Shareholder

SIOX

Sio Gene Therapies Inc. Healthcare

> 10% Shareholder

UROV

Urovant Sciences Ltd.

> 10% Shareholder

ADPT

Adaptive Biotechnologies Corp Healthcare

> 10% Shareholder

DNA

Ginkgo Bioworks Holdings, Inc. Healthcare

ZNTL

Zentalis Pharmaceuticals, Inc. Healthcare

> 10% Shareholder

INBX

Inhibrx, Inc. Healthcare

FDMT

4D Molecular Therapeutics, Inc. Healthcare

RLYB

Rallybio Corp Healthcare

FIGS

FIGS, Inc. Consumer Cyclical

> 10% Shareholder

PRCT

PROCEPT BioRobotics Corp Healthcare

APG

APi Group Corp Industrials

AMLX

Amylyx Pharmaceuticals, Inc. Healthcare

RYZB

RayzeBio, Inc.

FLAC

Frazier Lifesciences Acquisition Corp Financial Services

ROIV

Roivant Sciences Ltd. Healthcare

VGI